Snowball logo
logo
Оценка
Бета
-0,426
Другое
Размер лота
1 шт.
О компании
Тикер
AXRX
ISIN
US0311392072
Страна
США
Сектор (GICS)
Здравоохранение
Amexdrug Corporation, a pharmaceutical and cosmeceutical company, through its subsidiaries, primarily distributes pharmaceutical products. It is also involved in the research, development, manufacture, and sale of pharmaceutical drugs, cosmetics, and medical devices. The company operates in two segments, Distribution and Health and Beauty Products. In addition, it engages in the distribution of prescription and over-the-counter drugs, non-drug products, and health and beauty products; and private manufacturing and labeling activities. Further, the company manufactures and sells facial and body creams, arthritic pain relief medications, and hair and nail care products to pharmacies, beauty salons, beauty supply stores, and other fine shops. Amexdrug Corporation markets its products under the Sponix name. The company distributes its products through its subsidiaries primarily to independent pharmacies and secondarily to small-sized pharmacy chains, alternative care facilities, and other wholesalers and retailers in the state of California. The company was formerly known as Harlyn Products, Inc. and changed its name to Amexdrug Corporation in April 2000 to reflect the change in its business to the sale of pharmaceutical products. Amexdrug Corporation was founded in 1963 and is based in Commerce, California.

Часто задаваемые вопросы

В каком секторе работает Amexdrug Corporation (AXRX)?

Amexdrug Corporation относится к сектору Здравоохранение.

Какова текущая цена акций Amexdrug Corporation (AXRX)?

По последним данным, цена акций Amexdrug Corporation составляет 0,00 $, предыдущее закрытие — 0,00 $.

Выплачивает ли Amexdrug Corporation (AXRX) дивиденды?

Нет, Amexdrug Corporation не выплачивает дивиденды.

Какой бета-коэффициент (волатильность) у Amexdrug Corporation (AXRX)?

У компании Amexdrug Corporation бета -0.426, что указывает на более низкую волатильность по сравнению с рынком в целом.